Understanding the Gaps in the Reporting of COPD Exacerbations by Patients: A Review

Paul Jonesa Global Medical, Regulatory and Quality, GSK plc, Brentford, UKCorrespondence[email protected]
View further author information

Ashraf Alzaabib Internal Medicine Department, College of Medicine and Health Sciences, UAE University, Al Ain, UAE;c Respirology Department, Zayed Military Hospital, Abu Dhabi, UAEView further author information

Alejandro Casas Herrerad AIREPOC (Integrated care and rehabilitation program of COPD), Fundación Neumológica Colombiana, Bogotá, Colombia

https://orcid.org/0000-0003-4700-9822 View further author information

Mehmet Polatlie School of Medicine, Chest Disease Department, Aydin Adnan Menderes University, Aydin, TurkeyView further author information

Marcelo Fouad Rabahif Faculdade de Medicina da Universidade Federal de Goiás, Goiânia, BrazilView further author information

Arturo Cortes Tellesg Clínica de Enfermedades Respiratorias Hospital Regional de Alta Especialidad de la Península de Yucatán, Yucatán, MéxicoView further author information

Bhumika Aggarwalh Emerging Markets, GSK, SingaporeView further author information

Sudeep Acharyah Emerging Markets, GSK, SingaporeView further author information

Abdelkader El Hasnaouii Emerging Markets, GSK, Dubai, UAEView further author information

Chris Comptonj GSK, Brentford, UKView further author information

show all